|
End-of-day quote
Egyptian Exchange
|
||
| - EGP | - |
|
| 05-21 | The Arab Drug Company Reports Earnings Results for the Nine Months Ended March 31, 2026 | CI |
| 04-30 | Arab Drug Company 9-month net profit EGP 196.4 million | RE |
| Market Cap | 2.89B 56.72M 48.58M 45.46M 41.61M 78.09M 5.43B 79.13M 537M 209M 2.73B 213M 208M 9.02B | P/E 2024 |
5.46x | P/E 2025 | 6.08x |
|---|---|---|---|---|---|
| Enterprise Value | 3.32B 65.23M 55.87M 52.28M 47.85M 89.81M 6.24B 91M 618M 241M 3.14B 245M 240M 10.37B | EV / Sales 2024 |
0.98x | EV / Sales 2025 | 1.47x |
| Free-Float |
18.09% | Yield 2024 |
10.4% | Yield 2025 | 4.14% |
| Manager | Title | Age | Since |
|---|---|---|---|
Tariq Ali
DFI | Director of Finance/CFO | - | - |
Yosef Omr Amer
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | 30/09/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.88% | +6.38% | +76.40% | +126.75% | 1,119B | |
| +1.07% | +3.80% | +50.73% | +62.78% | 651B | |
| +1.20% | +6.21% | +25.81% | +78.74% | 468B | |
| +1.02% | +5.77% | +43.63% | +48.43% | 374B | |
| +0.85% | +4.07% | +24.97% | +40.58% | 302B | |
| +1.26% | +6.81% | +2.27% | +14.41% | 259B | |
| +1.88% | +5.81% | +49.57% | +70.53% | 238B | |
| +1.59% | +2.09% | -17.33% | -52.62% | 208B | |
| +1.87% | +5.61% | +27.32% | +91.38% | 181B | |
| Average | +1.29% | +4.97% | +31.49% | +53.44% | 422.21B | |
| Weighted average by Cap. | +1.14% | +5.09% | +44.26% | +72.65% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 786M 15.44M 13.23M 12.37M 11.33M 21.26M 1.48B 21.54M 146M 57.01M 742M 57.97M 56.71M 2.45B | 1.12B 21.98M 18.83M 17.62M 16.12M 30.26M 2.1B 30.66M 208M 81.16M 1.06B 82.52M 80.73M 3.49B |
| Net income | 103M 2.02M 1.73M 1.62M 1.48M 2.78M 193M 2.82M 19.14M 7.46M 97.14M 7.59M 7.42M 321M | 228M 4.48M 3.84M 3.59M 3.29M 6.17M 429M 6.25M 42.41M 16.54M 215M 16.82M 16.45M 712M |
| Net Debt | 284M 5.59M 4.79M 4.48M 4.1M 7.7M 535M 7.8M 52.93M 20.64M 269M 20.99M 20.53M 889M | 433M 8.51M 7.29M 6.82M 6.24M 11.72M 814M 11.87M 80.57M 31.42M 409M 31.95M 31.25M 1.35B |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
